# |
PMID |
Sentence |
1 |
7657031
|
Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
|
2 |
7657031
|
The enzymology of proinsulin conversion was studied in COS cells by cotransfection of three species of proinsulin and each of three conversion endoproteases (furin, PC2, and PC3).
|
3 |
7657031
|
PC2, by contrast, failed to cleave human proinsulin but was able to cleave both human proinsulin Arg62 and rat proinsulin II.
|
4 |
7657031
|
Cleavage by PC2 of these proinsulins was predominantly at the C-peptide-A-chain junction, generating the conversion intermediate des-64,65-split proinsulin as the major product and only very small amounts of insulin itself.
|
5 |
7657031
|
Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
|
6 |
7657031
|
The enzymology of proinsulin conversion was studied in COS cells by cotransfection of three species of proinsulin and each of three conversion endoproteases (furin, PC2, and PC3).
|
7 |
7657031
|
PC2, by contrast, failed to cleave human proinsulin but was able to cleave both human proinsulin Arg62 and rat proinsulin II.
|
8 |
7657031
|
Cleavage by PC2 of these proinsulins was predominantly at the C-peptide-A-chain junction, generating the conversion intermediate des-64,65-split proinsulin as the major product and only very small amounts of insulin itself.
|
9 |
7657031
|
Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
|
10 |
7657031
|
The enzymology of proinsulin conversion was studied in COS cells by cotransfection of three species of proinsulin and each of three conversion endoproteases (furin, PC2, and PC3).
|
11 |
7657031
|
PC2, by contrast, failed to cleave human proinsulin but was able to cleave both human proinsulin Arg62 and rat proinsulin II.
|
12 |
7657031
|
Cleavage by PC2 of these proinsulins was predominantly at the C-peptide-A-chain junction, generating the conversion intermediate des-64,65-split proinsulin as the major product and only very small amounts of insulin itself.
|
13 |
7657031
|
Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
|
14 |
7657031
|
The enzymology of proinsulin conversion was studied in COS cells by cotransfection of three species of proinsulin and each of three conversion endoproteases (furin, PC2, and PC3).
|
15 |
7657031
|
PC2, by contrast, failed to cleave human proinsulin but was able to cleave both human proinsulin Arg62 and rat proinsulin II.
|
16 |
7657031
|
Cleavage by PC2 of these proinsulins was predominantly at the C-peptide-A-chain junction, generating the conversion intermediate des-64,65-split proinsulin as the major product and only very small amounts of insulin itself.
|
17 |
14671193
|
Two principal components, PC1 and PC2 (55% of the variance), were used as metabolic syndrome phenotypes.
|
18 |
14671193
|
ANOVA was used to quantify the familial aggregation of PC1 and PC2.
|
19 |
14671193
|
Two principal components, PC1 and PC2 (55% of the variance), were used as metabolic syndrome phenotypes.
|
20 |
14671193
|
ANOVA was used to quantify the familial aggregation of PC1 and PC2.
|
21 |
15226261
|
Here we show that in orpk mice, a model system for PKD that harbors a mutation in the gene that encodes the polaris protein, pancreatic defects start to occur at the end of gestation, with an initial expansion of the developing pancreatic ducts.
|
22 |
15226261
|
Expression of polycystin-2, a protein involved in PKD, is mislocalized in orpk mice.
|
23 |
15226261
|
Furthermore, the cellular localization of beta-catenin, a protein involved in cell adhesion and Wnt signaling, is altered.
|
24 |
16801329
|
Renal histology and immunohistochemistry analyses of mutant fetuses revealed cysts derived from all nephron segments with multilayered epithelia and dysplastic regions, accompanied by a marked increase in the expression of beta-catenin and E-cadherin.
|
25 |
16801329
|
A significant proportion of cysts still expressed the cystic renal disease proteins, polycystin-1, polycystin-2, fibrocystin and uromodulin, implying that cyst formation may result from a deregulation of cell-cell adhesion and/or the Wnt/beta-catenin signaling pathway.
|
26 |
16801329
|
Both fetuses exhibited a severe pancreatic hypoplasia with underdeveloped and disorganized acini, together with an absence of ventral pancreatic-derived tissue. beta-catenin and E-cadherin were strongly downregulated in the exocrine and endocrine compartments, and the islets lacked the transporter essential for glucose-sensing GLUT2, indicating a beta-cell maturation defect.
|
27 |
17269447
|
In rodent islets, exposure to IL-1beta alone or combined with IFN-gamma induces expression of inducible nitric oxide synthase (iNOS).
|
28 |
17269447
|
In the removed grafts iNOS-/- islet tissue contained higher mRNA levels of insulin, proinsulin convertases (PC-1 and PC-2), and IL-1beta compared to transplanted wt islets.
|
29 |
17269447
|
The assessments of insulin, PC-1 and PC-2 mRNAs of the grafts suggest that the iNOS-/- islets may be more resistant to destruction in the transplantation model used; however, this was not sufficient to prolong the period of normoglycemia posttransplantation.
|
30 |
17269447
|
In rodent islets, exposure to IL-1beta alone or combined with IFN-gamma induces expression of inducible nitric oxide synthase (iNOS).
|
31 |
17269447
|
In the removed grafts iNOS-/- islet tissue contained higher mRNA levels of insulin, proinsulin convertases (PC-1 and PC-2), and IL-1beta compared to transplanted wt islets.
|
32 |
17269447
|
The assessments of insulin, PC-1 and PC-2 mRNAs of the grafts suggest that the iNOS-/- islets may be more resistant to destruction in the transplantation model used; however, this was not sufficient to prolong the period of normoglycemia posttransplantation.
|
33 |
22641569
|
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred.
|
34 |
23209428
|
Autosomal Dominant Polycystic Kidney Disease (ADPKD; MIM ID's 173900, 601313, 613095) leads to end-stage kidney disease, caused by mutations in PKD1 or PKD2.
|